Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry
Background Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the evaluation, management, and clinical consequences of thrombocytopenia occurring during heparin therapy in diverse clinical settings. Methods...
Saved in:
Published in | The American heart journal Vol. 157; no. 4; pp. 651 - 657 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Mosby, Inc
01.04.2009
Mosby Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the evaluation, management, and clinical consequences of thrombocytopenia occurring during heparin therapy in diverse clinical settings. Methods CATCH was a prospective observational study that enrolled 3,536 patients in 48 US hospitals. Data were collected on 3 strata: patients receiving any form of heparin for ≥96 hours (n = 2,420); cardiac care unit (CCU) patients treated with heparin who developed thrombocytopenia (n = 1,090); patients who had an HIT assay performed (n = 449). Results Thrombocytopenia occurred in 36.4% of patients in the prolonged heparin stratum and was associated with an increased risk of death or thromboembolic complication (OR 1.5, 95% CI 1.2-1.9). Among a subset of patients whose clinical presentation suggested they were at high risk for HIT, suspicion for HIT was uncommon (prolonged heparin stratum 19.8%, CCU stratum 37.6%) and often did not arise until ≥1 day after patients developed thrombocytopenia. Often patients were not evaluated for HIT until after they had had a thromboembolic complication (prolonged heparin stratum 43.8%, CCU stratum 61%). Even after HIT was suspected, patients often continued to receive heparin. Direct thrombin inhibitor use was infrequent (prolonged heparin stratum 29.4%, CCU stratum 35.6%). Among the few patients who underwent evaluation, HIT was confirmed in 46.7% of the prolonged heparin stratum and 31.4% of the CCU stratum. Conclusions Thrombocytopenia is common among patients receiving heparin, and it is associated with substantial risk for catastrophic complications. Despite the high risk for HIT in this population, recognition, evaluation, and appropriate treatment are infrequent and delayed. |
---|---|
AbstractList | Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the evaluation, management, and clinical consequences of thrombocytopenia occurring during heparin therapy in diverse clinical settings.
CATCH was a prospective observational study that enrolled 3,536 patients in 48 US hospitals. Data were collected on 3 strata: patients receiving any form of heparin for > or =96 hours (n = 2,420); cardiac care unit (CCU) patients treated with heparin who developed thrombocytopenia (n = 1,090); patients who had an HIT assay performed (n = 449).
Thrombocytopenia occurred in 36.4% of patients in the prolonged heparin stratum and was associated with an increased risk of death or thromboembolic complication (OR 1.5, 95% CI 1.2-1.9). Among a subset of patients whose clinical presentation suggested they were at high risk for HIT, suspicion for HIT was uncommon (prolonged heparin stratum 19.8%, CCU stratum 37.6%) and often did not arise until > or =1 day after patients developed thrombocytopenia. Often patients were not evaluated for HIT until after they had had a thromboembolic complication (prolonged heparin stratum 43.8%, CCU stratum 61%). Even after HIT was suspected, patients often continued to receive heparin. Direct thrombin inhibitor use was infrequent (prolonged heparin stratum 29.4%, CCU stratum 35.6%). Among the few patients who underwent evaluation, HIT was confirmed in 46.7% of the prolonged heparin stratum and 31.4% of the CCU stratum.
Thrombocytopenia is common among patients receiving heparin, and it is associated with substantial risk for catastrophic complications. Despite the high risk for HIT in this population, recognition, evaluation, and appropriate treatment are infrequent and delayed. Background Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the evaluation, management, and clinical consequences of thrombocytopenia occurring during heparin therapy in diverse clinical settings. Methods CATCH was a prospective observational study that enrolled 3,536 patients in 48 US hospitals. Data were collected on 3 strata: patients receiving any form of heparin for ≥96 hours (n = 2,420); cardiac care unit (CCU) patients treated with heparin who developed thrombocytopenia (n = 1,090); patients who had an HIT assay performed (n = 449). Results Thrombocytopenia occurred in 36.4% of patients in the prolonged heparin stratum and was associated with an increased risk of death or thromboembolic complication (OR 1.5, 95% CI 1.2-1.9). Among a subset of patients whose clinical presentation suggested they were at high risk for HIT, suspicion for HIT was uncommon (prolonged heparin stratum 19.8%, CCU stratum 37.6%) and often did not arise until ≥1 day after patients developed thrombocytopenia. Often patients were not evaluated for HIT until after they had had a thromboembolic complication (prolonged heparin stratum 43.8%, CCU stratum 61%). Even after HIT was suspected, patients often continued to receive heparin. Direct thrombin inhibitor use was infrequent (prolonged heparin stratum 29.4%, CCU stratum 35.6%). Among the few patients who underwent evaluation, HIT was confirmed in 46.7% of the prolonged heparin stratum and 31.4% of the CCU stratum. Conclusions Thrombocytopenia is common among patients receiving heparin, and it is associated with substantial risk for catastrophic complications. Despite the high risk for HIT in this population, recognition, evaluation, and appropriate treatment are infrequent and delayed. Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the evaluation, management, and clinical consequences of thrombocytopenia occurring during heparin therapy in diverse clinical settings. CATCH was a prospective observational study that enrolled 3,536 patients in 48 US hospitals. Data were collected on 3 strata: patients receiving any form of heparin for ≥96 hours (n = 2,420); cardiac care unit (CCU) patients treated with heparin who developed thrombocytopenia (n = 1,090); patients who had an HIT assay performed (n = 449). Thrombocytopenia occurred in 36.4% of patients in the prolonged heparin stratum and was associated with an increased risk of death or thromboembolic complication (OR 1.5, 95% CI 1.2-1.9). Among a subset of patients whose clinical presentation suggested they were at high risk for HIT, suspicion for HIT was uncommon (prolonged heparin stratum 19.8%, CCU stratum 37.6%) and often did not arise until ≥1 day after patients developed thrombocytopenia. Often patients were not evaluated for HIT until after they had had a thromboembolic complication (prolonged heparin stratum 43.8%, CCU stratum 61%). Even after HIT was suspected, patients often continued to receive heparin. Direct thrombin inhibitor use was infrequent (prolonged heparin stratum 29.4%, CCU stratum 35.6%). Among the few patients who underwent evaluation, HIT was confirmed in 46.7% of the prolonged heparin stratum and 31.4% of the CCU stratum. Thrombocytopenia is common among patients receiving heparin, and it is associated with substantial risk for catastrophic complications. Despite the high risk for HIT in this population, recognition, evaluation, and appropriate treatment are infrequent and delayed. |
Author | Crespo, Eric M., MD, MPH Ohman, E. Magnus, MD Anstrom, Kevin J., PhD Abrams, Charles S., MD Moll, Stephan, MD Rice, Lawrence, MD Rodgers, Jo E., PharmD Steinhubl, Steven R., MD Tapson, Victor F., MD Berger, Peter B., MD Granger, Christopher B., MD Moliterno, David J., MD Becker, Richard C., MD Honeycutt, Emily F., MBI Oliveira, Gustavo B.F., MD Kleiman, Neal S., MD |
Author_xml | – sequence: 1 fullname: Crespo, Eric M., MD, MPH – sequence: 2 fullname: Oliveira, Gustavo B.F., MD – sequence: 3 fullname: Honeycutt, Emily F., MBI – sequence: 4 fullname: Becker, Richard C., MD – sequence: 5 fullname: Berger, Peter B., MD – sequence: 6 fullname: Moliterno, David J., MD – sequence: 7 fullname: Anstrom, Kevin J., PhD – sequence: 8 fullname: Abrams, Charles S., MD – sequence: 9 fullname: Kleiman, Neal S., MD – sequence: 10 fullname: Moll, Stephan, MD – sequence: 11 fullname: Rice, Lawrence, MD – sequence: 12 fullname: Rodgers, Jo E., PharmD – sequence: 13 fullname: Steinhubl, Steven R., MD – sequence: 14 fullname: Tapson, Victor F., MD – sequence: 15 fullname: Granger, Christopher B., MD – sequence: 16 fullname: Ohman, E. Magnus, MD |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21416196$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19332191$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt9qFDEUxoNU7Hb1AbyRgAj1Ytb8mWRmFIRlqVYoeGG9DtlM0s06k0yTmcL28Xwyz3YXCxW8Sk74nfOdnO-coZMQg0XoNSULSqj8sF3ozXbBCGkWhC4IEc_QjJKmKmRVlidoRghhRV0RforOct5CKFktX6BT2nDOaENn6PfFne4mPfoYsA4t7nXQN7a3YcTR4XGTYr-OZjfGwQavH5A85cGa0bZ4YwedfCh8aCcD8T-4D3gT8-BH3fl7AAYQgtL5I77eWLyK_dB58yCe8dKNNsH7kxIrPWXIXO_w5UENn6-W16vL9zjZG5_HtHuJnjvdZfvqeM7Rzy8XQBRX379-Wy2vCiM4GQvZipLJNasorZ3QztCaV6Yt24q11GjOmJBU85o6pqUwpahdY10jeSl51QjH5-jtoe6Q4u1k86i2cUoBJBUVpBQNEbwBih4ok2LOyTo1JN_rtFOUqL1raqvANbV3TRGqwDXIeXOsPK172z5mHG0C4N0R0NnoziUdjM9_OUZLKim0OkefDpyFOdx5m1Q2MHDwxiewTLXR_7eNz0-yTecDGNT9sjubH3-rMlNE_div1367SAM3IWv-B2kQzvo |
CODEN | AHJOA2 |
CitedBy_id | crossref_primary_10_1161_CIR_0b013e3182742cf6 crossref_primary_10_1016_j_clinthera_2010_04_012 crossref_primary_10_3918_jsicm_25_143 crossref_primary_10_1053_j_jvca_2013_10_004 crossref_primary_10_1002_rth2_12169 crossref_primary_10_1093_ckj_sft139 crossref_primary_10_1002_ajh_24025 crossref_primary_10_1056_NEJMct1206642 crossref_primary_10_1177_1076029613491346 crossref_primary_10_1177_1076029617721013 crossref_primary_10_1016_j_iccl_2015_01_002 crossref_primary_10_1155_2015_985253 crossref_primary_10_1016_j_jacc_2016_02_073 crossref_primary_10_33140_JCRC_03_04_00005 crossref_primary_10_3109_15563650_2014_917181 crossref_primary_10_1016_S1553_7250_11_37020_1 crossref_primary_10_1097_MJT_0b013e3181f65503 crossref_primary_10_1161_CIR_0000000000000909 crossref_primary_10_1007_s11239_011_0631_4 crossref_primary_10_1016_j_thromres_2018_03_017 crossref_primary_10_1097_CCM_0b013e3181de0b88 crossref_primary_10_1177_1076029612456732 crossref_primary_10_1097_01_NPR_0000397911_98068_26 crossref_primary_10_1111_j_1538_7836_2011_04402_x crossref_primary_10_1186_cc12822 crossref_primary_10_1016_j_healun_2009_08_016 crossref_primary_10_1016_j_jacc_2012_11_019 crossref_primary_10_1182_blood_2015_07_660001 crossref_primary_10_1097_MOH_0b013e32833c07a7 crossref_primary_10_36290_vnl_2020_157 crossref_primary_10_1002_jca_21400 crossref_primary_10_1177_1062860610366033 crossref_primary_10_1053_j_jvca_2010_12_015 crossref_primary_10_1016_j_autrev_2018_05_003 crossref_primary_10_1053_j_jvca_2009_06_009 crossref_primary_10_1002_pds_1654 crossref_primary_10_1097_ACO_0b013e3283357df6 crossref_primary_10_2165_1120090_000000000_00000 crossref_primary_10_1007_s11239_016_1467_8 crossref_primary_10_1161_CIRCULATIONAHA_109_853135 crossref_primary_10_1177_1076029612474840s |
Cites_doi | 10.1007/s11239-005-0850-7 10.1055/s-0037-1615866 10.1161/01.CIR.95.11.2508 10.1023/A:1027372901367 10.1161/01.CIR.0000147537.72829.1B 10.1056/NEJMcp052967 10.1016/S1062-0303(05)80003-2 10.1111/j.1538-7836.2006.01787.x 10.1378/chest.126.3_suppl.311S 10.1023/A:1027325002276 10.1023/A:1027333320023 |
ContentType | Journal Article |
Copyright | Mosby, Inc. 2009 Mosby, Inc. 2009 INIST-CNRS Copyright Elsevier Limited Apr 2009 |
Copyright_xml | – notice: Mosby, Inc. – notice: 2009 Mosby, Inc. – notice: 2009 INIST-CNRS – notice: Copyright Elsevier Limited Apr 2009 |
CorporateAuthor | on behalf of the CATCH Registry Investigators CATCH Registry Investigators |
CorporateAuthor_xml | – name: on behalf of the CATCH Registry Investigators – name: CATCH Registry Investigators |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QO 7RV 7TS 7X7 7XB 88C 88E 8AO 8C1 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH K9. KB0 M0S M0T M1P M2O MBDVC NAPCQ P64 PQEST PQQKQ PQUKI PRINS Q9U |
DOI | 10.1016/j.ahj.2009.01.005 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals Physical Education Index ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) ProQuest Healthcare Administration Database PML(ProQuest Medical Library) ProQuest_Research Library Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China Physical Education Index ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6744 |
EndPage | 657 |
ExternalDocumentID | 3238056351 10_1016_j_ahj_2009_01_005 19332191 21416196 S0002870309000568 1_s2_0_S0002870309000568 |
Genre | Multicenter Study Comparative Study Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 08R 0R 1 1- 1B1 1P 1RT 1~. 1~5 23M 354 3O- 3V. 4.4 41 457 4G. 53G 55 5GY 5RE 5VS 6J9 7-5 71M 7RV 7X7 88E 8AO 8C1 8F7 8FI 8FJ 8G5 8P 9JM AABNK AACTN AAEDT AAIAV AAIKJ AAKOC AALMO AALRI AAOAW AAPBV AAQFI AAQQT AAQXK AAWTL AAXUO AAYOK ABBQC ABFLS ABFNM ABFRF ABLJU ABLVK ABMAC ABMZM ABOCM ABPIF ABPPZ ABQIS ABUWG ABWYI ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIWK ACPRK ACRLP ADALY ADBBV ADEZE ADFRT AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AN0 ANZVX AQUVI ASPBG AVWKF AZFZN AZQEC BBAFP BENPR BKEYQ BKOJK BLXMC BNPGV BNQBC BPHCQ BVXVI C45 CAG COF CS3 DWQXO EBS EFJIC EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FO FYUFA G- G-2 G-Q GBLVA GJ GNUQQ GUQSH HEB HMK HMO HVGLF HZ IH2 IHE IPNFZ J1W J5H K K-O KOM L7B LCYCR M M0T M1P M29 M2O M41 MO0 N4W N9A NAPCQ O-L O9- OA. OAUVE OBH OHH OHT OL OVD OZT P-8 P-9 P2P PADUT PC. PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q38 R2- RIG ROL RPZ SAE SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UGJ UHS UKR UV1 WH7 WOW WUQ X7M XCE XZ YOC Z5R ZA5 ZGI ZXP ZY1 --- --K --M .1- .55 .FO .GJ .XZ .~1 0R~ 1CY 1P~ 41~ 8P~ AAEDW ABJNI ADMUD AHPSJ AXJTR CCPQU EFLBG FYGXN HMCUK HZ~ OL~ UKHRP YYM YYP ~G- AAUGY AKALU IQODW AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7TS 7XB 8FD 8FK FR3 K9. MBDVC P64 Q9U |
ID | FETCH-LOGICAL-c530t-6d5426b27118f5afc1837cd4d72d1ca322561a381f2a65c458f9ef963463795f3 |
IEDL.DBID | .~1 |
ISSN | 0002-8703 |
IngestDate | Fri Sep 13 09:22:05 EDT 2024 Thu Sep 26 19:19:33 EDT 2024 Sat Sep 28 07:45:01 EDT 2024 Sun Oct 22 16:07:19 EDT 2023 Fri Feb 23 02:34:19 EST 2024 Thu Aug 18 17:13:03 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Thrombocytopenia Evaluation Platelet Complication Cardiovascular disease Hemopathy Circulatory system Heparin Cardiology |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c530t-6d5426b27118f5afc1837cd4d72d1ca322561a381f2a65c458f9ef963463795f3 |
PMID | 19332191 |
PQID | 1504590539 |
PQPubID | 2031075 |
PageCount | 7 |
ParticipantIDs | proquest_journals_1504590539 crossref_primary_10_1016_j_ahj_2009_01_005 pubmed_primary_19332191 pascalfrancis_primary_21416196 elsevier_sciencedirect_doi_10_1016_j_ahj_2009_01_005 elsevier_clinicalkeyesjournals_1_s2_0_S0002870309000568 |
PublicationCentury | 2000 |
PublicationDate | 2009-04-01 |
PublicationDateYYYYMMDD | 2009-04-01 |
PublicationDate_xml | – month: 04 year: 2009 text: 2009-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: Philadelphia |
PublicationTitle | The American heart journal |
PublicationTitleAlternate | Am Heart J |
PublicationYear | 2009 |
Publisher | Mosby, Inc Mosby Elsevier Limited |
Publisher_xml | – name: Mosby, Inc – name: Mosby – name: Elsevier Limited |
References | Lee, Warkentin (bib2) 2001 Warkentin (bib8) 2004; 110 Arepally, Ortel (bib10) 2006; 355 Warkentin, Greinacher (bib5) 2004; 126 Greinacher (bib12) 1999; 82 Spencer (bib3) 2000; 10 Walenga, Jeske, Messmore (bib4) 2000; 10 Berkowitz, Granger, Pieper (bib7) 1997; 95 Ohman, Granger, Rice (bib6) 2005; 19 Lo, Juhl, Warkentin (bib9) 2006; 4 Fahey (bib1) 1995; 13 Lubenow, Greinacher (bib11) 2000; 10 Greinacher (10.1016/j.ahj.2009.01.005_bib12) 1999; 82 Walenga (10.1016/j.ahj.2009.01.005_bib4) 2000; 10 Warkentin (10.1016/j.ahj.2009.01.005_bib8) 2004; 110 Warkentin (10.1016/j.ahj.2009.01.005_bib5) 2004; 126 Lo (10.1016/j.ahj.2009.01.005_bib9) 2006; 4 Arepally (10.1016/j.ahj.2009.01.005_bib10) 2006; 355 Spencer (10.1016/j.ahj.2009.01.005_bib3) 2000; 10 Berkowitz (10.1016/j.ahj.2009.01.005_bib7) 1997; 95 Ohman (10.1016/j.ahj.2009.01.005_bib6) 2005; 19 Lubenow (10.1016/j.ahj.2009.01.005_bib11) 2000; 10 Fahey (10.1016/j.ahj.2009.01.005_bib1) 1995; 13 Lee (10.1016/j.ahj.2009.01.005_bib2) 2001 |
References_xml | – volume: 126 start-page: 311S year: 2004 end-page: 337S ident: bib5 article-title: Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy publication-title: Chest contributor: fullname: Greinacher – start-page: 87 year: 2001 end-page: 121 ident: bib2 article-title: Frequency of heparin-induced thrombocytopenia publication-title: Heparin-induced Thrombocytopenia contributor: fullname: Warkentin – volume: 10 start-page: 21 year: 2000 end-page: 25 ident: bib3 article-title: Heparin-induced thrombocytopenia: patient profiles and clinical manifestations publication-title: J Thromb Thrombolysis contributor: fullname: Spencer – volume: 19 start-page: 11 year: 2005 end-page: 19 ident: bib6 article-title: Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease publication-title: J Thromb Thrombolysis contributor: fullname: Rice – volume: 95 start-page: 2508 year: 1997 end-page: 2516 ident: bib7 article-title: Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators publication-title: Circulation contributor: fullname: Pieper – volume: 4 start-page: 759 year: 2006 end-page: 765 ident: bib9 article-title: Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings publication-title: J Thromb Haemost contributor: fullname: Warkentin – volume: 10 start-page: 13 year: 2000 end-page: 20 ident: bib4 article-title: Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia publication-title: J Thromb Thrombolysis contributor: fullname: Messmore – volume: 355 start-page: 809 year: 2006 end-page: 817 ident: bib10 article-title: Clinical practice. Heparin-induced thrombocytopenia publication-title: N Engl J Med contributor: fullname: Ortel – volume: 13 start-page: 112 year: 1995 end-page: 116 ident: bib1 article-title: Heparin-induced thrombocytopenia publication-title: J Vasc Nurs contributor: fullname: Fahey – volume: 110 start-page: e454 year: 2004 end-page: e458 ident: bib8 article-title: Heparin-induced thrombocytopenia: diagnosis and management publication-title: Circulation contributor: fullname: Warkentin – volume: 10 start-page: 47 year: 2000 end-page: 57 ident: bib11 article-title: Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin publication-title: J Thromb Thrombolysis contributor: fullname: Greinacher – volume: 82 start-page: 457 year: 1999 end-page: 467 ident: bib12 article-title: Treatment of heparin-induced thrombocytopenia publication-title: Thromb Haemost contributor: fullname: Greinacher – volume: 19 start-page: 11 year: 2005 ident: 10.1016/j.ahj.2009.01.005_bib6 publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-005-0850-7 contributor: fullname: Ohman – volume: 82 start-page: 457 year: 1999 ident: 10.1016/j.ahj.2009.01.005_bib12 article-title: Treatment of heparin-induced thrombocytopenia publication-title: Thromb Haemost doi: 10.1055/s-0037-1615866 contributor: fullname: Greinacher – volume: 95 start-page: 2508 year: 1997 ident: 10.1016/j.ahj.2009.01.005_bib7 article-title: Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators publication-title: Circulation doi: 10.1161/01.CIR.95.11.2508 contributor: fullname: Berkowitz – volume: 10 start-page: 13 issue: Suppl 1 year: 2000 ident: 10.1016/j.ahj.2009.01.005_bib4 article-title: Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia publication-title: J Thromb Thrombolysis doi: 10.1023/A:1027372901367 contributor: fullname: Walenga – volume: 110 start-page: e454 year: 2004 ident: 10.1016/j.ahj.2009.01.005_bib8 article-title: Heparin-induced thrombocytopenia: diagnosis and management publication-title: Circulation doi: 10.1161/01.CIR.0000147537.72829.1B contributor: fullname: Warkentin – volume: 355 start-page: 809 year: 2006 ident: 10.1016/j.ahj.2009.01.005_bib10 article-title: Clinical practice. Heparin-induced thrombocytopenia publication-title: N Engl J Med doi: 10.1056/NEJMcp052967 contributor: fullname: Arepally – volume: 13 start-page: 112 year: 1995 ident: 10.1016/j.ahj.2009.01.005_bib1 article-title: Heparin-induced thrombocytopenia publication-title: J Vasc Nurs doi: 10.1016/S1062-0303(05)80003-2 contributor: fullname: Fahey – volume: 4 start-page: 759 year: 2006 ident: 10.1016/j.ahj.2009.01.005_bib9 article-title: Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2006.01787.x contributor: fullname: Lo – start-page: 87 year: 2001 ident: 10.1016/j.ahj.2009.01.005_bib2 article-title: Frequency of heparin-induced thrombocytopenia contributor: fullname: Lee – volume: 126 start-page: 311S issue: Suppl 3 year: 2004 ident: 10.1016/j.ahj.2009.01.005_bib5 article-title: Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy publication-title: Chest doi: 10.1378/chest.126.3_suppl.311S contributor: fullname: Warkentin – volume: 10 start-page: 21 issue: Suppl 1 year: 2000 ident: 10.1016/j.ahj.2009.01.005_bib3 article-title: Heparin-induced thrombocytopenia: patient profiles and clinical manifestations publication-title: J Thromb Thrombolysis doi: 10.1023/A:1027325002276 contributor: fullname: Spencer – volume: 10 start-page: 47 issue: Suppl 1 year: 2000 ident: 10.1016/j.ahj.2009.01.005_bib11 article-title: Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin publication-title: J Thromb Thrombolysis doi: 10.1023/A:1027333320023 contributor: fullname: Lubenow |
SSID | ssj0006286 |
Score | 2.1727414 |
Snippet | Background Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the... Thrombocytopenia and heparin-induced thrombocytopenia (HIT) are potentially devastating paradoxical side effects of heparin therapy. We explored the... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 651 |
SubjectTerms | Aged Anticoagulants - adverse effects Anticoagulants - therapeutic use Biological and medical sciences Blood platelets Cardiology. Vascular system Cardiovascular Clinical medicine Coronary Disease - drug therapy Female Heart attacks Hematologic and hematopoietic diseases Hematology Heparin - adverse effects Heparin - therapeutic use HIV Hospitalization Human immunodeficiency virus Humans Incidence Inpatients Male Medical sciences Medical treatment Middle Aged Platelet diseases and coagulopathies Probability Prognosis Prospective Studies Registries Risk Factors Statistical analysis Studies Thrombocytopenia - chemically induced Thrombocytopenia - epidemiology Thrombosis |
SummonAdditionalLinks | – databaseName: ProQuest Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELVKkRBShfhsA23lAwdAMhs7sbPhglZRqxVSuUCl3iw7trVbqdmFZA_l5_HLmMnXQml7jezYyTzPPNtjP0LeWogKSsQJU9YKlqbeMhukZbmBYGSld65dyj77qubn6ZcLebFD5sNZGEyrHHxi66jdqsQ18gkQl1TmAJl8YiyuApTN5PP6B0P9KNxn7cU0HpCHHCCKIg7TYpvsgQcwRyIMIB_2N9tML7O47C-u5B9j1LG7PULtrU0N_y10ghd3M9I2Mp0-JU96SklnHQaekR1fPSePzvpN8xfk98l4ozc1laNXY8YLXQWKOglXdlVeNyiktTRtkXrTnsD0ji48yhRWDKbuAAL3f_FlRRe99sjyFxToL2qtP1FAIC3-zlinMxQkh-c3XlGYTQ017TWdd63Rd8XsezF_T1E2AtXoXpLz0xN4wnrpBlbKJG6YchJCvxUZzF-CNKEEz5GVLnWZcLw06EUUN8AWgjBKlqmchtwHcAapSrJchuQV2a1WlT8glIcAtAkM6FyWehebLPFSeKtcLjLjQkQ-DObS6-6GDj2krl1qsC0qbeY65hpsG5FsMKgejp6Cs_R1P3JrzXUtdKy_teuO6A5bVVU1jUg61uzJSUc6NMSe-xo8_gc2YxcFx6llriJyOOBIbzsxgj0i-x22tt-WJwmEGf76_opvyONh4yvmh2S3-bnxR8CfGnvcDo0_6u0cEQ priority: 102 providerName: ProQuest |
Title | Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0002870309000568 https://dx.doi.org/10.1016/j.ahj.2009.01.005 https://www.ncbi.nlm.nih.gov/pubmed/19332191 https://www.proquest.com/docview/1504590539/abstract/ |
Volume | 157 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhVIope84TYMOPbQFJ5ZtSVFuG7Nh25KllAb2JiRLYh2Id6l3D8mhP66_rCNb9ubR9tCLbYRkyZrRzMiamQ-hdxq0AkuTLGZap3GeWx1rR3UsFCgjTa0x7a_ssymbnOefZ3S2hYo-Fsa7VQbZ38n0VlqHksMwm4fLqvIxvok_pcuSFveS-YDfHJQR8PTBz42bhw-9HExgqN2fbLY-Xmp-EVJWkoPEI9j9WTc9XqoGZsx1UBd_t0VbnXT6FD0JxiQedeN9hrZs_Rw9PAvH5S_Qr_GQyxur2uDLwdcFLxz2CAmXelFerTyEVqXaKs26jb20Bs-tByisY9i0A_nN_epVjecBdaS6hgohRWtzjIH3cHHTVx2PPBQ5lN95RaHWDbTUV3jS9YbfF6PvxeQD9oARHofuJTo_HUNJHEAb4pJmySpmhoLS1ymHnYujypUgM3hpcsNTQ0rl5QcjCuwElypGy5weOWEdiIGcZVxQl71C2_WitjsIE-fAYAICGsNzaxLFM0tTq5kRKVfGRehjTy657HJzyN5p7UICbT3GppAJkUDbCPGeoLIPOgUxaZuwZhtJZJPKRN7jqwjlQ8tbrClB6_yrw_1bbDMMMSV-UylYhPZ6PpKbQVCwsQVIRhGh1x1vbb5NZBkoGLL7fwN6gx71R2EJ2UPbqx9r-xYsqpXeb5cMXPmMw_WogOcHo09fJlO4n4ynX7_9BgNEJcE |
link.rule.ids | 315,786,790,4521,12083,12250,21416,24144,27957,27958,31754,33301,33779,43345,43614,43840,45620,45714,74102,74371,74659 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSICEEK_SQCk-cAAkt4ljO3Uv1SpqtUC3F1qpN8uObe1WanZLdg_l5_HLGCdOlmevkR07mfHM5_F4PoTeGfAKgqY5EcZQwpgzxHhuiNTgjAx31rah7MmpGJ-zzxf8IgbcmphW2dvE1lDbeRVi5HsAXBiXoDLycHFNAmtUOF2NFBp30T2Wg6MJN8XLdYpHuHY5wF9Q7f5Us83v0tPLWK4y200De92__dKjhW7gb_mO5uL_OLT1R8dP0OMIJPGok_xTdMfVz9D9STwqf45-HA11vLGuLb4a8lzw3OPAjnBl5tXNMtBnzXTbpFm19y6dxVMXyAlrAht2EL39u_msxtPIODL7Dg1iedbmAIPe4fLXPHU8CjTk8PyPV5R61UBPc4PH3Wj4fTk6K8cfcCCLCBx0L9D58RE8IZGwgVQ8T5dEWA4O39ACdi2ea1-BvSgqy2xBbVbpYDtEpgEjeKoFrxjf99J5MAFM5IXkPt9EG_W8dlsIZ94DWAIBWlswZ1Nd5I5TZ4SVtNDWJ-hjLy616OpyqD5h7VKBbAO_plRppkC2CSp6gar-wimYSNfE9dqoTDVUpeprG20MRrDlUhX7CWJDzwhJOqihwOPcNuDOb2ozTJFmYUMpRYK2ez1S60kMKp6gl51urb9N5jk4l-zV7R3fogfjs8mJOvl0-uU1etgffaXZNtpYflu5N4CglmanXSY_AQ5BG0c |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgkyYkNHEnbAw_8ABIZrn4MvOCSmlVLqsmYNLeLDu21U5aWkj7sP28_TKOEyfjutfIjp2cz-d8to_9IfTcQFTgeVoQbkxOKHWGGM8MkRqCkWHO2mYp-3DKJ8f04wk7iflPdUyr7Hxi46jtogxr5PtAXCiTABm572NaxNH78dvldxIUpMJOa5TTuIk2BeUMEL75bjQ9-tL75XAIsyfDAPRuj7PJ9tKz03h5ZfY6DVp2_45St5e6hn_nW9GL_7PSJjqN76DtSCvxoMXBXXTDVffQ1mHcOL-PLkf9rd5YVxaf9VkveOFx0Eo4M4vyfBXEtOa6KVKvm1OYzuKZC1KFFYHpOwDB_l18XuFZ1B-ZX0CBeFlr_QYDCvHw16x1PAii5PD8j1cM9bqGmuYcT9rW8Ivh4Ntw8hIH6YigSPcAHY9H8IRE-QZSsiJdEW4ZhH-TC5jDeKZ9Cd5DlJZakdus1MGT8EwDY_C55qyk7MBL58EhUF4IyXzxEG1Ui8o9RjjzHqgTGNBaQZ1NtSgcy53hVuZCW5-gV5251LK9pUN16WunCmwb1DalSjMFtk2Q6AyquuOn4DBdHUdvrTJV5ypVX5u1x-ASG2VVfpAg2teMBKUlHgriz3UN7v0Gm76LeRaml5InaLfDkbrqRA_4BD1qsXX1bbIoINRkT66v-AxtwRhRnz9MP-2gW90-WJrtoo3Vj7V7CnRqZfbiOPkJhzkhHw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+and+management+of+thrombocytopenia+and+suspected+heparin-induced+thrombocytopenia+in+hospitalized+patients%3A+The+Complications+After+Thrombocytopenia+Caused+by+Heparin+%28CATCH%29+registry&rft.jtitle=The+American+heart+journal&rft.au=Crespo%2C+Eric+M.&rft.au=Oliveira%2C+Gustavo+B.F.&rft.au=Honeycutt%2C+Emily+F.&rft.au=Becker%2C+Richard+C.&rft.date=2009-04-01&rft.pub=Mosby%2C+Inc&rft.issn=0002-8703&rft.eissn=1097-6744&rft.volume=157&rft.issue=4&rft.spage=651&rft.epage=657&rft_id=info:doi/10.1016%2Fj.ahj.2009.01.005&rft.externalDocID=S0002870309000568 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00028703%2FS0002870309X00049%2Fcov150h.gif |